AzTrials
AzTrials

Stress Urinary IncontinenceNCT05773716

Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence

A study testing Pelvic floor muscle training and Electroacupuncture in people with Stress Urinary Incontinence, run by RenJi Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical study is to compare the effects of combined electroacupuncture with pelvic floor muscle training (PFMT) versus PFMT alone in the treatment of involuntary urine leakage following prostate removal procedure due to prostate cancer. Read more about this study

Who is it for?
Ages 45 to 80 years, men only
Conditions the study is for
Stress Urinary Incontinence
What is being tested?
Pelvic floor muscle training and Electroacupuncture
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteChina
Study dates
1 Apr 2023to 30 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 80 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients present stress urinary incontinence 6 weeks after radical prostatectomy
  • Aged between 45-80 years
  • With an urine leakage amount over 1g measured by the one-hour pad test
  • Participate voluntarily with signed the informed consent

Who cannot join

  • The existence of stress urinary incontinence symptoms before the surgery
  • Urine leakage due to urgency incontinence, voiding dysfunction, nocturnal enuresis and fistula
  • Known history of radiation therapy to the pelvic region
  • Evidence of tumor recurrence or metastasis
  • Those who have already underwent treatment for stress urinary incontinence
  • Patients with hemorrhagic disease or hemorrhagic tendency
Show all 10Show fewer
  • The presence of ulcer, abscess and skin infection at locations of target acupoints
  • With histories of cardiac pacemaker, intravascular stent and metal allergy
  • With poor health conditions due to coexisting of acute comorbidities of the heart, brain, lung and kidney
  • Those who refuse to sign the informed consent and unable to comply with the study protocol

Trial locations and contacts

1 site in 1 country.

China1 site
  • Renji Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, 200127

Other trials in China

About this study

Official title: The Effects of Combination Therapy With Electroacupuncture and Pelvic Floor Muscle Training on Stress Urinary Incontinence Following Radical Prostatectomy: A Randomized Controlled Trial

The goal of this clinical study is to compare the effects of combined electroacupuncture with pelvic floor muscle training (PFMT) versus PFMT alone in the treatment of involuntary urine leakage following prostate removal procedure due to prostate cancer. The main goal is to determine that whether adding electroacupuncture to PFMT provides extra benefits in relieving urinary leakage and improves patients' quality of life. All participants will be required to perform daily PFMT for 6 weeks using uniformed standards. During the meantime, those assigned to the experimental group will additionally receive electroacupuncture three times per week for 6 weeks, while those in control group will receive sham treatment with same duration. Researchers will compare the urine leakage severity between the two groups to see if adding electroacupuncture can facilitate the recovery of symptom.

Read the detailed description

This randomized controlled trial will recruit patients presenting stress urinary incontinence 6 weeks after radical prostatectomy, with the aim to determine whether adding electroacupuncture therapy to pelvic floor muscle training (PFMT) provides extra benefits in relieving stress urinary incontinence following radical prostatectomy. Followed by signing the informed consent and baseline assessments, participants with be randomly allocated to either PFMT plus electroacupuncture arm or PFMT plus sham electroacupuncture arm in a 1:1 ratio.

Pelvic floor muscle training will be conducted daily using a consistent approach. In short, before training, the patients are required to empty the bladder and relax the whole body in a sitting or lying position. The contraction of the pelvic floor muscles is maintained for 2-6 seconds, followed by a relaxation for 2-6 seconds. This process is repeated 10 times per session, three sessions per day (in the morning, afternoon and evening), and performed daily for 6 continuous weeks.

Electroacupuncture will be performed at bilateral Zhongliao, Huiyang, Zhongji, Guanyuan and Dahe, three treatment sessions per week for 6 consecutive weeks. For sham electroacupuncture, The same acupoints will be punctured as that in treatment group, except the use of blunt-tipped needles (identical in appearance compared with normal needles) to puncture through the fixed pad and to reach the skin surface. In both groups, the needles will be clamped by electrodes which are connected to a pulse generator (Huatuo SDZ- EA, Suzhou, China). In consistency with our previous settings, continuous wave with frequency of 50Hz will be used. The current intensity is gradually increased ranging from 1mA to 5mA, according to the patient's tolerance.

Patients will be appraised at baseline, 3, 6, 10 and 18 weeks after the initiation of treatments to determine the changes of incontinence symptom, quality of life and pelvic structures. The primary outcome is the change of urine leakage amount during a 1-hour pad test at 6-week timepoint. The secondary outcomes include parameters derived from the International Consultation on Incontinence Modular Questionnaire - urinary incontinence short form, mean 24-hour pad use, pelvic magnetic resonance imaging (except for those with contraindications, such as metallic implants or psychological disorders), and the documentation of adverse events.

The statistical analysis of the baseline and outcomes at each timepoint is based on the intention-to-treat population. In addition, the data analysis of the primary outcome is also based on the per-protocol population as a supportive analysis. Quantitative variables will be compared using either independent t-tests or Mann-Whitney U-tests based on their normality. The statistical significance between nominal variables will be detected using Pearson's chi-squared tests or Fisher's exact tests. Statistical analysis will be performed using both SPSS software and R package, and the level of significance will be set at <0.05.

Being tested
Pelvic floor muscle training, Electroacupuncture, Sham electroacupuncture
Keywords
Incontinence, Radical prostatectomy, Men, Pelvic floor muscle training, Acupuncture, Bladder diary, Pad test
Medical subject headings
Urinary Incontinence, Stress, Multiple Endocrine Neoplasia Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pelvic floor muscle trainingBehavioural

    Participants will receive daily pelvic floor muscle training for 6 consecutive weeks. In specific, they will be instructed to perform 3 training sessions (morning, afternoon and evening) per day with an emptied bladder in a relaxed state. During each session, 10 muscle stretches are required with each contraction duration of 2~6-second and a 2~6-second relaxation following each one.

  • ElectroacupunctureOther

    Participants will also receive electroacupuncture at bilateral Zhongliao (BL33), Huiyang (BL35), Zhongji (CV3), Guanyuan (CV4) and Dahe (KI12). During each therapy session, the electroacupuncture stimulation of acupoints in the abdomen and sacral regions will last for 30 minutes in total (15 minutes for each region) with a continuous wave of 50 Hz and a current intensity of 1 to 5 mA (preferably with the skin around the acupoints shivering mildly without pain). Participants will receive 3 treatment sessions per week (ideally every other day) for 6 consecutive weeks, 18 sessions in total.

  • Sham electroacupunctureOther

    Sham electroacupuncture will be carried out with pragmatic placebo needles on the same acupoints in the experimental group. Procedures, electrode placements, and other treatment settings will also stay the same but with no electrical stimulation output.

Study groups in NCT05773716
Study groupRoleWhat they receive
Electroacupuncture plus pelvic floor muscle trainingExperimentalParticipants in this arm will receive pelvic floor muscle training using unified standards, and electroacupuncture therapy for 6 weeks.
Receives: Behavioral: Pelvic floor muscle training; Other: Electroacupuncture
Sham electroacupuncture plus pelvic floor muscle trainingSham comparatorParticipants in this arm will receive pelvic floor muscle training using the same approach as that in experimental group, and sham electroacupuncture for 6 weeks.
Receives: Behavioral: Pelvic floor muscle training; Other: Sham electroacupuncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The change of urine leakage amount at 6 weeks

    The 1-hour pad test will be applied to quantitatively measure the changes of the urine leakage severity. In specific, patients will be asked to wear pre-weighed pads and drink 500 ml of sodium-free liquid in <15 minutes. After rest, they are instructed to exercise for 30 minutes, including: walking, climbing up and down one flight of stairs, standing-up from sitting (10 times), coughing vigorously (10 times), running on the spot for 1 minute, bending to pick up an object from the floor (5 times) and washing hands for 1 minute in running water. Before and after the test, the weight of the pad is measured with a high-precision balance in order to determine the amount of leakage. For this test, an increase of 1 to 10 g represents mild incontinence, 11 to 50 g represents moderate incontinence, and >50 g represents severe incontinence.

    Measured: measured at baseline and 6 weeks after treatment

Secondary outcomes (14)
  1. One-hour pad test at 3, 10, 18 weeks

    For the 1-hour pad test, patients will be asked to wear pre-weighed pads and drink 500 ml of sodium-free liquid in <15 minutes. After rest, they are instructed to exercise for 30 minutes, including: walking, climbing up and down one flight of stairs, standing-up from sitting (10 times), coughing vigorously (10 times), running on the spot for 1 minute, bending to pick up an object from the floor (5 times) and washing hands for 1 minute in running water. Before and after the test, the weight of the pad is measured with a high-precision balance in order to determine the amount of leakage. For this test, an increase of 1 to 10 g represents mild incontinence, 11 to 50 g represents moderate incontinence, and >50 g represents severe incontinence.

    Measured: measured at 3, 10 and 18 weeks after treatment

  2. The status of 24-hour pad use

    The 24-hour pad use will be recorded as the average daily pad number in three continuous days

    Measured: measured at baseline, 6 and 18 weeks after treatment

  3. Urinary incontinence questionnaires

    The patient-reported continence status will be evaluated by the International Consultation on Incontinence Modular Questionnaire - urinary incontinence short form (ICIQ-UI-SF). The total score will be calculated based on three questions, namely the frequency of leakage (scores from 0 to 5 points), the amount of leakage (scores 0, 2, 4 or 6 points) and the impact of leakage (scores from 0 to 10 points).

    Measured: measured at baseline, 3, 6, 10 and 18 weeks after treatment

  4. Pelvic Magnetic resonance imaging

    The pelvic magnetic resonance imaging (MRI) will be performed with a 1.5-T scanner with the patients in a supine position. The imaging protocol included a transversal T1-weighted 2D gradient echo sequence. High-spatial-resolution T2-weighted TSE sequences will be obtained in the axial, coronal and sagittal orientation. Several parameters will be measured, including membranous urethral length (mm), urethral wall thickness (mm), levator ani muscle thickness (mm), obturator internus muscle thickness (mm) etc. Besides, the position of the bladder neck, the shape of the bladder and the presence of a dilated posterior urethra will also be recorded. The MRI can be waived if contraindications are noted, such as metallic implants or psychological disorders.

    Measured: measured at baseline, 6 and 18 (optional) weeks after treatment

  5. Adverse events

    Although electroacupuncture is well-known as a minimally invasive therapy which can be carried out in the clinic, the adverse events will be carefully documented by the researchers base on the patients' subjective report.

    Measured: measured at 3, 6, 10 and 18 weeks after treatment

  6. Data of birth

    The date of birth will be recorded as year/month/date.

    Measured: documented at baseline

  7. Height

    The height will be measured in meters.

    Measured: documented at baseline

  8. Weight

    The weight will be measured in kilograms.

    Measured: documented at baseline

  9. Body mass index (BMI)

    The BMI is calculated as weight (kg) / height (m^2)

    Measured: documented at baseline

  10. Comorbidites

    The comorbidities, such as hypertension, diabetes and stroke etc., will be recorded by patient-self report.

    Measured: documented at baseline

  11. The duration after radical prostatectomy

    The duration is calculated as the days between the date of recruitment and the date of radical prostatectomy.

    Measured: documented at baseline

  12. The TNM tumor staging

    The TNM tumor staging is recorded according to the pathology report after radical prostatectomy.

    Measured: documented at baseline

  13. The radical prostatectomy technique

    Whether the neurovasulcar preservation technique and lymph node dissection was performed is achieved according to the surgery record.

    Measured: documented at baseline

  14. The presence of positive surgical margin

    This is recorded according to the pathology report after radical prostatectomy.

    Measured: documented at baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2023
  2. Study start1 Apr 2023
  3. Primary completion1 Dec 2024
  4. Study completion30 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05773716
Sponsor's protocol ID
ST2023
Status last verified
Jul 2025
First submitted
19 Jan 2023
Last updated
24 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The IPD will be made available to other researchers upon reasonable request after the publication of this trial.

Publications

  • Tang K, Su T, Fu L, Chen Z, Liu G, Hou W, Ming S, Song Q, Feng S, Liu X, Wang R, Liu B, Chen Y. Effect of Electroacupuncture Added to Pelvic Floor Muscle Training in Women with Stress Urinary Incontinence: A Randomized Clinical Trial. Eur Urol Focus. 2023 Mar;9(2):352-360. doi: 10.1016/j.euf.2022.10.005. Epub 2022 Oct 26.

    PubMed 36420937
  • Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, Li N, Lu Y, Su T, Sun J, Wang J, Yue Z, Zhang W, Zhao J, Zhou Z, Wu J, Zhou K, Ai Y, Zhou J, Pang R, Wang Y, Qin Z, Yan S, Li H, Luo L, Liu B. Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA. 2017 Jun 27;317(24):2493-2501. doi: 10.1001/jama.2017.7220.

    PubMed 28655016
  • Su T, Zhou J, Liu Z, Chen Y, Zhang W, Chu H, Luo Q, Lu J, An J, Liu B. The efficacy of electroacupuncture for the treatment of simple female stress urinary incontinence - comparison with pelvic floor muscle training: study protocol for a multicenter randomized controlled trial. Trials. 2015 Feb 8;16:45. doi: 10.1186/s13063-015-0560-1.

    PubMed 25887231
  • Geraerts I, Van Poppel H, Devoogdt N, Joniau S, Van Cleynenbreugel B, De Groef A, Van Kampen M. Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trial. Eur Urol. 2013 Nov;64(5):766-72. doi: 10.1016/j.eururo.2013.01.013. Epub 2013 Jan 21.

    PubMed 23357349
  • Ribeiro LH, Prota C, Gomes CM, de Bessa J Jr, Boldarine MP, Dall'Oglio MF, Bruschini H, Srougi M. Long-term effect of early postoperative pelvic floor biofeedback on continence in men undergoing radical prostatectomy: a prospective, randomized, controlled trial. J Urol. 2010 Sep;184(3):1034-9. doi: 10.1016/j.juro.2010.05.040.

    PubMed 20643454
  • Bi X, Chen Y, Wu R, Gao W, Fan Q, Wang S, Pan J, Xue W, Song QX, Tang K. The effects of combination therapy with electroacupuncture and pelvic floor muscle exercise on stress urinary incontinence following radical prostatectomy: the protocol for a randomized controlled trial. Front Surg. 2025 Dec 16;12:1490210. doi: 10.3389/fsurg.2025.1490210. eCollection 2025.

    PubMed 41477477

Questions about this trial

What is this clinical trial studying?

A study testing Pelvic floor muscle training and Electroacupuncture in people with Stress Urinary Incontinence, run by RenJi Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The change of urine leakage amount at 6 weeks (time frame: measured at baseline and 6 weeks after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05773716, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in